Sclerotherapy (Foam/Liquid)

Treatment for Varicose Veins

Typical Dosage: Polidocanol 0.5-3%, up to 10-15mL per session

Effectiveness
80%
Safety Score
75%
Clinical Trials
4
Participants
25K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
Polidocanol 0.5-3%, up to 10-15mL per session
Time to Effect
2-6 weeks
Treatment Duration
Multiple sessions (2-4)
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$200
Side Effect Mgmt:$100
Total Annual:$2,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$18,000/QALY
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$3,200
Cost per Remission
$3,692
Comparison vs No treatment
Cost Difference
+$2,400/year
More expensive
QALY Difference
+0.08 QALYs
Better outcomes
Dominance
No dominance
Sclerotherapy (Foam/Liquid) Outcomes

for Varicose Veins

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Remission Rate
+65%
Common Side Effects
Hyperpigmentation
+25%
Localized pain/burning
+15%
Skin ulceration
+3%
Transient visual disturbances/headache (with foam)
+7%
Allergic reactions
+0.8%
Deep Vein Thrombosis (DVT)
+0.3%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
3 active trials recruiting for Sclerotherapy (Foam/Liquid) in Varicose Veins

Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment

NCT07162844ACTIVE NOT RECRUITINGNA
View Study
508 participants
INTERVENTIONAL
Kafr ash Shaykh, Egypt
Started: Sep 5, 2024

Caprini Score in Venous Surgery: a Prospective Cohort Study

NCT03041805RECRUITING
View Study
3K participants
OBSERVATIONAL
Moscow, Russia
Started: Jan 1, 2017

Observation of Pain During the Treatment of Great Saphenous Vein Using Microwave Ablation, and Analysis of Related Factors

NCT06693245RECRUITING
View Study
155 participants
OBSERVATIONAL
Chengdu, China
Started: Dec 1, 2024